These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1500083)

  • 1. Purification of a novel B cell growth and differentiation factor associated with lupus syndrome.
    Kanai Y; Tanuma S
    Immunol Lett; 1992 Mar; 32(1):43-8. PubMed ID: 1500083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural occurrence of Nuc in the sera of autoimmune-prone MRL/lpr mice.
    Kanai Y; Miura K; Uehara T; Amagai M; Takeda O; Tanuma S; Kurosawa Y
    Biochem Biophys Res Commun; 1993 Oct; 196(2):729-36. PubMed ID: 8240349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of autoreactive T cells that help nucleobindin-injected mice produce anti-DNA antibodies.
    Kubota T; Watanabe N; Kaneko T; Satake F; Miura K; Kurosawa Y; Miyasaka N; Kanai Y
    Immunol Lett; 2001 Jan; 75(2):111-5. PubMed ID: 11137134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced expression of nucleobindin in lymphatic organs of lupus-prone mice.
    Iizuka H; Kubota T; Satake F; Hirokawa G; Miura K; Kurosawa Y; Miyasaka N; Kanai Y
    Lupus; 1997; 6(4):365-70. PubMed ID: 9175021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of autoantibodies in normal mice by injection of nucleobindin and natural occurrence of antibodies against nucleobindin in autoimmune MRL/lpr/lpr mice.
    Kanai Y; Takeda O; Miura K; Amagai M; Kaneko T; Kubota T; Kanai Y; Tanuma S; Kurosawa Y
    Immunol Lett; 1995 Feb; 45(1-2):35-42. PubMed ID: 7622185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel autoimmune phenomena induced in vivo by a new DNA binding protein Nuc: a study on MRL/n mice.
    Kanai Y; Takeda O; Kanai Y; Miura K; Kurosawa Y
    Immunol Lett; 1993 Dec; 39(1):83-9. PubMed ID: 8144193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early induction of anti-double-stranded DNA antibodies in lupus-prone MRL mice inoculated with Ly-24+ cells cloned from lymph node cells of an MRL/Mp-lpr/lpr mouse: possible effect of putative cytokines produced by cloned Ly-24+ cells.
    Kanai Y; Isonishi S; Katagiri T; Koizumi T; Miura K; Kurosawa Y
    Immunol Lett; 1990; 24(1):49-55. PubMed ID: 2197220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cloning of nucleobindin, a novel DNA-binding protein that contains both a signal peptide and a leucine zipper structure.
    Miura K; Titani K; Kurosawa Y; Kanai Y
    Biochem Biophys Res Commun; 1992 Aug; 187(1):375-80. PubMed ID: 1520323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype.
    Prud'Homme GJ; Park CL; Fieser TM; Kofler R; Dixon FJ; Theofilopoulos AN
    J Exp Med; 1983 Feb; 157(2):730-42. PubMed ID: 6600490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyclonal B cell activation by a B cell differentiation factor, B151-TRF2. III. B151-TRF2 as a B cell differentiation factor closely associated with autoimmune disease.
    Dobashi K; Ono S; Murakami S; Takahama Y; Katoh Y; Hamaoka T
    J Immunol; 1987 Feb; 138(3):780-7. PubMed ID: 3543118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction and natural occurrence of serum nucleosomal DNA in autoimmune MRL/lpr/lpr mice: its relation to apoptosis in the thymus.
    Kanai Y; Kyuwa S; Miura K; Kurosawa Y
    Immunol Lett; 1995 May; 46(1-2):207-14. PubMed ID: 7590921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA binding to mouse cells is mediated by cell-surface molecules: the role of these DNA-binding molecules as target antigens in murine lupus.
    Hefeneider SH; McCoy SL; Morton JI; Bakke AC; Cornell KA; Brown LE; Bennett RM
    Lupus; 1992 May; 1(3):167-73. PubMed ID: 1301977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
    Merino R; Iwamoto M; Fossati L; Izui S
    J Immunol; 1993 Dec; 151(11):6509-16. PubMed ID: 7902378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Kanda N; Tsuchida T; Tamaki K
    Arthritis Rheum; 1999 Feb; 42(2):328-37. PubMed ID: 10025928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of autoantibody production is limited in nonautoimmune mice.
    Singh RR; Ebling FM; Albuquerque DA; Saxena V; Kumar V; Giannini EH; Marion TN; Finkelman FD; Hahn BH
    J Immunol; 2002 Jul; 169(1):587-94. PubMed ID: 12077292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of in vitro NZB antibody responses by cyclosporine.
    Pisetsky DS
    Clin Exp Immunol; 1988 Jan; 71(1):155-8. PubMed ID: 3258202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of interleukin-10 and of interleukin-12 on the in vitro production of anti-double-stranded DNA antibodies from patients with systemic lupus erythematosus.
    Tyrrell-Price J; Lydyard PM; Isenberg DA
    Clin Exp Immunol; 2001 Apr; 124(1):118-25. PubMed ID: 11359450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cell dependence on and response to accessory signals in murine lupus strains.
    Prud'homme GJ; Balderas RS; Dixon FJ; Theofilopoulos AN
    J Exp Med; 1983 Jun; 157(6):1815-27. PubMed ID: 6406639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression.
    Kitani A; Hara M; Hirose T; Harigai M; Suzuki K; Kawakami M; Kawaguchi Y; Hidaka T; Kawagoe M; Nakamura H
    Clin Exp Immunol; 1992 Apr; 88(1):75-83. PubMed ID: 1563109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prednisone treatment inhibits the differentiation of B lymphocytes into plasma cells in MRL/MpSlac-lpr mice.
    Yan SX; Deng XM; Wang QT; Sun XJ; Wei W
    Acta Pharmacol Sin; 2015 Nov; 36(11):1367-76. PubMed ID: 26456588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.